BREVEL (946409)

  https://cordis.europa.eu/project/id/946409

  Horizon 2020 (2014-2020)

  Industrial scale-up of a novel and disruptive microalgae photobioreactor

  SME instrument (EIC-SMEInst-2018-2020)

  proteins  ·  lipids  ·  biomass  ·  botany  ·  fermentation

  2020-02-01 Start Date (YY-MM-DD)

  2022-10-31 End Date (YY-MM-DD)

  € 1,675,890 Total Cost

  Description

Brevel developed a disruptive microalgae cultivation technology which dramatically reduces the cultivation costs for light-dependent microalgae and enables penetration into new and yet untapped markets where microalgae biomass and derived products are much desired. The technology is based on shifting from very large, relatively inefficient and labour-intensive outdoor cultivation system to completely closed, sterile and fully automated indoor photobioreactors which are efficiently illuminated from within and are capable of continuous mixotrophic cultivation which combines photosynthesis with fermentation processes. The patented Brevel mixotrophic cultivation technology has been successfully demonstrated on a large scale with surprising results of more than 90% cost reduction and up to 200 higher yields per land compared to current outdoor state-of-the-art photobioreactors. Conditions are finally ripe for the next big stage of mass production. Capitalizing on the technological advancement, a first pilot factory capable of producing 400 tonnes of biomass annually will be constructed and the first use case of salmon feed supplements will be addressed to replace the current unsustainable synthetic alternative at comparable costs. Next, additional markets including protein and fatty acids from a sustainable source at affordable costs will be approached.

  Complicit Organisations

1 Israeli organisation participates in BREVEL.